Bristol-Myers Squibb Company (BMY)

Number of days of payables

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Payables turnover		8.63	10.08	9.25	8.84	9.36	11.42	10.24	10.04	10.24	9.08	5.58	5.30	4.34	4.65	3.73	3.23	3.30	3.84	3.54	3.40
Number of days of payables	days	42.27	36.20	39.44	41.29	39.01	31.95	35.63	36.36	35.66	40.18	65.41	68.84	84.11	78.46	97.81	112.97	110.48	94.97	103.16	107.22

December 31, 2023 calculation

Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 8.63
= 42.27

Analyzing Bristol-Myers Squibb Co.'s number of days of payables over the past eight quarters provides insight into the company's efficiency in paying off its suppliers. The trend suggests that the number of days of payables has been fluctuating over this period.

In Q4 2023, the number of days of payables increased to 111.24 days compared to the prior quarter at 97.40 days. This may indicate that the company took longer to pay its suppliers during this period. However, it is important to note that this figure fluctuated over the past quarters, with similar fluctuations observed in previous years.

Overall, a higher number of days of payables could suggest that the company is taking longer to settle its obligations, potentially signaling cash flow management strategies or changes in the company's payment terms with suppliers. Further analysis of Bristol-Myers Squibb Co.'s working capital management and supplier relationships would provide a more comprehensive understanding of the factors influencing these fluctuations in the number of days of payables.